Venus ConceptVERO
About: Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Employees: 304
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
40% more capital invested
Capital invested by funds: $1.06M [Q1] → $1.48M (+$419K) [Q2]
14% more funds holding
Funds holding: 14 [Q1] → 16 (+2) [Q2]
5.61% more ownership
Funds ownership: 24.09% [Q1] → 29.7% (+5.61%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for VERO.
